Debut Plus

₹820.85

▼ -7.96 -0.96%

As of 23 Oct 2026 · delayed

NSE Listed

Aarti Pharmalabs Limited (AARTIPHARM)

Volume: 7,02,860Avg Vol 1W: 5,05,432.2Avg Vol 1M: 5,98,638.3552W Range:₹585₹1,002.4
Market Cap₹7,443 Cr
Current Price₹820.85
Previous Close₹828.81
High / Low (52w)₹1,002.4 / ₹585
Volume7,02,860
Avg Vol (1W)5,05,432.2
Avg Vol (1M)5,98,638.35
Stock P/E34.58
Book Value₹234.3
Dividend Yield43%
ROE8.22%
ROA6.12%
Revenue (TTM)₹1,829 Cr
Revenue Growth14.2%
Profit Margin10.82%
Total Debt₹104 Cr
Shares Outstanding9 Cr
Face Value₹5
EPS (TTM)₹23.74
P/B3.5
Debt / Equity0.28
50 DMA₹868.43
200 DMA₹742.66
Day change-0.96%
Price Chart
₹820.85▼ 1.10% · 1Y
₹975₹5921.5Cr
2025-10-27
2026-10-23

20-day avg volume: 6.0L shares

Pros
  • Pays a dividend yield of 43.0%.
  • Company is almost debt-free.
Cons
  • Company is loss-making at the latest annual result.
Quarterly Results
MetricSept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Revenue₹458 Cr₹538 Cr₹564 Cr₹386 Cr₹418 Cr₹432 Cr₹583 Cr₹536 Cr
EBITDA₹77 Cr₹111 Cr₹121 Cr₹74 Cr₹50 Cr₹73 Cr₹93 Cr₹107 Cr
Net Profit₹55 Cr₹74 Cr₹88 Cr₹50 Cr₹28 Cr₹48 Cr₹61 Cr₹76 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2025Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Mar 2026Jun 2026
Revenue₹530 Cr₹2,125 Cr₹375 Cr₹417 Cr₹425 Cr₹1,829 Cr₹580 Cr₹535 Cr
EBITDA₹120 Cr₹388 Cr₹74 Cr₹52 Cr₹74 Cr₹275 Cr₹99 Cr₹109 Cr
Net Profit₹89 Cr₹272 Cr₹51 Cr₹31 Cr₹44 Cr₹175 Cr₹62 Cr₹71 Cr
EPS—30.04———19.25——
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹0 Cr₹0 Cr₹2,040 Cr₹2,244 Cr₹2,582 Cr₹2,906 Cr₹3,482 Cr
Total Liabilities₹0 Cr₹0 Cr₹653 Cr₹686 Cr₹825 Cr₹917 Cr₹1,357 Cr
Equity₹0 Cr₹0 Cr₹1,386 Cr₹1,558 Cr₹1,757 Cr₹1,990 Cr₹2,125 Cr
Total Debt₹0 Cr——————
Cash Flow
MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹0 Cr₹-23 Cr₹312 Cr₹273 Cr₹395 Cr₹309 Cr
Investing₹0 Cr₹-139 Cr₹-158 Cr₹-215 Cr₹-412 Cr₹-431 Cr
Financing₹0 Cr₹260 Cr₹-163 Cr₹10 Cr₹65 Cr₹171 Cr
Free Cash Flow₹0 Cr₹-23 Cr₹313 Cr₹273 Cr₹395 Cr₹309 Cr
Shareholding
Promoter 39.66% Institutions 16.55% Public 43.79%
Efficiency & Working Capital
ROCE9.6%
Interest Coverage6
Dividend Payout—
Debtor Days117 d
Inventory Days128 d
Payable Days67 d
Cash Conversion Cycle178 d
Working Capital Days245 d
Shareholding Details

As of 2026-09-30

Promoter39.7%
FII8.2%
DII8.4%
Institutions16.6%
Public43.8%
Promoter Pledge12%
No. of Shareholders1,74,329
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodDec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026Sept 2026
Promoters46.5%46.5%46.5%46.1%44.7%44.3%43.7%42.9%43.1%43.1%42.9%39.7%
FIIs8.2%8.3%7.1%7.4%8.6%7.4%7.3%8%7.7%8.4%8.2%8.2%
DIIs9.9%10%11.5%11.3%10.4%7.5%7.8%7%7.7%7.4%7.2%8.4%
Public35.5%35.2%35%35.2%36.3%40.8%41.1%42.1%41.6%41.1%41.7%43.8%
Promoter Pledge0%0%0%0%0%0%0%0%0%11%11.1%12%
No. of Shareholders2,15,7962,04,1221,89,0121,85,4361,85,1111,96,3141,87,0391,90,6551,84,4891,79,3731,76,5061,74,329
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Life Insurance Corporation Of IndiaPublic Shareholding4.7%42,82,452
Rashesh Chandrakant GogriShareholding of Promoter and Promoter Group4.2%38,34,404
Jaya Chandrakant GogriShareholding of Promoter and Promoter Group3.5%32,04,310
Anushakti Enterprise Private LimitedShareholding of Promoter and Promoter Group3.3%29,92,950
Labdhi Business Trust(saswat Trusteeship Private Limited)Shareholding of Promoter and Promoter Group3.1%28,41,504
Hetal Gogri GalaShareholding of Promoter and Promoter Group3.1%28,15,612
Mirik Rajendra GogriShareholding of Promoter and Promoter Group3.1%27,84,094
Renil Rajendra GogriShareholding of Promoter and Promoter Group2.8%25,42,750
Sarla Shantilal ShahShareholding of Promoter and Promoter Group2.7%24,35,830
Manomaya Business Trust(alabhya Trusteeship Private Limited)Shareholding of Promoter and Promoter Group1.4%13,08,496
Nehal GarewalShareholding of Promoter and Promoter Group1.2%11,22,487
Rajendra Vallabhaji GogriShareholding of Promoter and Promoter Group1.1%10,37,175
Nishant Pradip ShahPublic Shareholding1.1%9,97,427
Heena Family Private Trust(barclays Wealth Trustees India Private Limited)Shareholding of Promoter and Promoter Group0.9%8,33,859
Bhavna Family Private Trust(barclays Wealth Trustees India Pvt Ltd)Shareholding of Promoter and Promoter Group0.9%8,04,101
Nikhil Parimal DesaiShareholding of Promoter and Promoter Group0.7%6,66,754
Alchemie Financial Services LimitedShareholding of Promoter and Promoter Group0.7%6,73,006
Aarnav Rashesh GogriShareholding of Promoter and Promoter Group0.6%5,50,000
Aashay Rashesh GogriShareholding of Promoter and Promoter Group0.6%5,50,000
Manisha Rashesh GogriShareholding of Promoter and Promoter Group0.6%5,50,000
Safechem Enterprises Private LimitedShareholding of Promoter and Promoter Group0.4%3,65,750
Parimal Hasmukhlal DesaiShareholding of Promoter and Promoter Group0.4%3,49,571
Ratanben Premji GogriShareholding of Promoter and Promoter Group0.4%3,44,332
Gogri Finserv Pvt. Ltd.Shareholding of Promoter and Promoter Group0.4%3,37,505
Heena BhatiaShareholding of Promoter and Promoter Group0.4%3,22,588
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Mirik Rajendra Gogri27,84,094100%2026-09-30
Renil Rajendra Gogri15,19,91959.8%2026-09-30
Board of Directors
NameDesignationYear
Chandrakant V GogriChairman Emeritus2025
Rashesh C GogriChairman(Non Exe)&Dir(Non-Ind)2025
Hetal Gogri GalaVice Chairman / Executive Director / MD2025
Narendra Jagannath SalviExecutive Director & MD2025
Rajendra V GogriNon-Exec & Non-Independent Dir2025
Parimal H DesaiNon-Exec & Non-Independent Dir2025
Vinay Gopal NayakIndependent Non Exe. Director2025
Bhavesh R VoraIndependent Non Exe. Director2025
Vilas G GaikarIndependent Non Exe. Director2025
Rupal VoraIndependent Non Exe. Director2025
Jeenal SavlaIndependent Non Exe. Director2025
Pradeep ThakurIndependent Non Exe. Director2025
NEHAL GAREWALNon-Exec & Non-Independent Dir2025
Jeevan MondkarCS / Compliance Officer / Legal Head2025
Segments — Product
SegmentRevenueShare
Pharmacuticals₹0 Cr—
Segments — Geography
RegionRevenueShare
Within India₹790 Cr44%
Outside India₹980 Cr54.5%
others₹27 Cr1.5%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹5504545
Corporate Actions
TypeDateValueRemark
forthcoming2026-09-15Dividend—
dividend2026-09-15₹2 (40%)Final
forthcoming2026-08-07Board Meetings—
dividend2026-02-16₹1.5 (30%)Interim
dividend2025-09-15₹2.5 (50%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20261206013262346
202600001818
202600313116132
Insider / Designated-Person Trades

25 recent disclosure(s)

RAJENDRA VALLABHAJI GOGRIDisposal · 3,88,725
Gloire Trusteeship Services Private LimitedDisposal · 3,97,500
Relacion Trusteeship Services Private LimitedDisposal · 3,80,000
ARTI RAJENDRA GOGRIDisposal · 1,33,564
Relacion Trusteeship Services Private LimitedDisposal · 6,27,500
Gloire Trusteeship Services Private LimitedDisposal · 6,24,500
Company Information
Incorporated2019
ChairmanRashesh C Gogri
AuditorGokhale & Sathe
Investor Email[email protected] ; investorrelations@aar
🌐 www.aartipharmalabs.com ↗

📍 Plot No 22/C/1 & 22/C/2, 1st Phase GIDC Vapi, Valsad, Gujarat, 396195

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search